Wednesday, April 11, 2018 5:22:43 PM
https://www.reuters.com/article/us-johnson-johnson-divestiture/johnson-johnson-nears-diabetes-device-exit-with-2-1-billion-lifescan-sale-idUSKCN1GS1G0
https://ih.advfn.com/news/amp/77047270?pid=nmona&article=77047270&__twitter_impression=true
J&J has till mid June to accept the offer which can be extended till the end of the year of 2018 worse case scenario.
Now if I was J&J of course I would settle with DECN for up to $500M in order to be able to the sell the division to get over $2B. Business 101.
DECN chart tells the story!
https://www.stockscores.com/charts/charts/?ticker=Decn
Everything is IMHO. Do your own DD. I don't make you push buttons. You do. Glad I could clear that up for you.
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM